Research article India
10.26502/fjr.26880050Different Dosing Regimens of Rituximab Biosimilar in Rheumatoid Arthritis: A Comparative Analysis of Disease Activity Control, B-cell Depletion and Adverse Effect Profile
Published On: 2025-10-27 Authors: Syamasis Bandyopadhyay, Aheli Ghosh Dastidar, Sandip Kumar Chandra.
Impact Factor: * 1.7
Acceptance Rate: 74.36% 
Time to first decision: 10.4 days 
Time from article received to acceptance: 2-3 weeks 